Consortional assoc.: Cytogenetic and immunology markers predicting the outcome and late sequel of radiation therapy  Page description

Help  Print 
Back »

 

Details of project

 
Identifier
124937
Type K
Principal investigator Jurányi, Zsolt
Title in Hungarian Konzorcium, társ p.: Prosztata tumoros betegek túlélésének és a sugárterápia következtében kialakuló késői mellékhatások kockázatának a becslésére alkalmas citogenetikai és immunológiai markereknek az azonosítása
Title in English Consortional assoc.: Cytogenetic and immunology markers predicting the outcome and late sequel of radiation therapy
Keywords in Hungarian sugárterápia, citogenetika, immunológia, késői mellékhatások
Keywords in English radiotherapy, cytogenetics, immunology, late side effects
Discipline
Cancer and its biological basis (Council of Medical and Biological Sciences)85 %
Radiology, nuclear medicine and imaging, radiation therapy (Council of Medical and Biological Sciences)15 %
Ortelius classification: Radiotherapy
Panel Immunity, Cancer and Microbiology
Department or equivalent Dept. of Radiobiology and Diagnostic Onco-Cytogenetics (National Institute of Oncology)
Participants Ágoston, Péter
Farkas, Gyöngyi
Kocsis, Zsuzsa
Polgár, Csaba
Székely, Gábor
Starting date 2017-09-01
Closing date 2021-08-31
Funding (in million HUF) 14.748
FTE (full time equivalent) 11.40
state running project




Back »